POLYMED

Poly Medicure Share Price

₹2,839.25
+ 23.95 (0.85%)
07 November, 2024 02:37 BSE: 531768 NSE: POLYMED ISIN: INE205C01021

Start SIP in Poly Medicure

Start SIP

Poly Medicure Performance

Day Range

  • Low 2,810
  • High 2,860
₹ 2,839

52 Week Range

  • Low 1,361
  • High 3,358
₹ 2,839
  • Open Price2,825
  • Previous Close2,815
  • Volume191499

Poly Medicure Chart

  • Over 1 Month + 20.95%
  • Over 3 Month + 56.51%
  • Over 6 Month + 68.65%
  • Over 1 Year + 94.14%

Poly Medicure Key Statistics

P/E Ratio 97.6
PEG Ratio 3.7
Market Cap Cr 28,769
Price to Book Ratio 19.6
EPS 23.3
Dividend 0.1
Relative Strength Index 61.52
Money Flow Index 67.4
MACD Signal 104.66
Average True Range 154.07

Poly Medicure Investment Rating

  • Master Rating:
  • Poly Medicure Ltd. is a leading Indian manufacturer of medical devices, specializing in infusion therapy, dialysis, urology, and diagnostics. With 8 global manufacturing facilities, it delivers high-quality healthcare products to patients and healthcare providers worldwide.

    Poly Medicure has an operating revenue of Rs. 1,522.46 Cr. on a trailing 12-month basis. An annual revenue growth of 25% is outstanding, Pre-tax margin of 25% is great, ROE of 17% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 14% and 47% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 4% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 85 which is a GOOD score indicating consistency in earnings, a RS Rating of 88 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 5 indicates it belongs to a strong industry group of Medical-Systems/Equip and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has great fundamentals and technical strength to stay in momentum.

    Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Poly Medicure Financials
IndicatorSep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 402367361321320306293
Operating Expenses Qtr Cr 290266264236237220212
Operating Profit Qtr Cr 1131019784838582
Depreciation Qtr Cr 20191616151515
Interest Qtr Cr 3333222
Tax Qtr Cr 30242321192016
Net Profit Qtr Cr 87727161596157
IndicatorMar 2024Mar 2023
Total Revenue Annual Cr 1,3651,104
Operating Expenses Annual Cr 958804
Operating Profit Annual in Cr 350264
Depreciation Cr 6256
Interest Annual Cr 118
Tax Annual Cr 8358
Net Profit Annual Cr 252179
IndicatorMar 2024Mar 2023
Cash from Operating Activity Annual Cr 256195
Cash from Investing Activity Annual Cr -237-187
Cash from Financing Annual Activity Cr -17-8
Net Cash Flow Annual Cr 20
IndicatorMar 2024Mar 2023
Total ShareHolders Funds Annual Cr 1,4581,234
Fixed Assets Annual Cr 902676
Total Non Current Assets Annual Cr 1,030782
Total Current Assets Annual Cr 792756
Total Assets Annual Cr 1,8211,538
IndicatorMar 2024Mar 2023
Book Value Per Share Annual Rs 152129
ROE Annual % 1715
ROCE Annual % 2319
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 3128
IndicatorSep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 420385378340337321307
Operating Expenses Qtr Cr 305281281249253234224
Operating Profit Qtr Cr 1151049790848783
Depreciation Qtr Cr 21201616161615
Interest Qtr Cr 3333222
Tax Qtr Cr 31242423192016
Net Profit Qtr Cr 87746865626359
IndicatorMar 2024Mar 2023
Total Revenue Annual Cr 1,4351,151
Operating Expenses Annual Cr 1,018850
Operating Profit Annual in Cr 358265
Depreciation Cr 6457
Interest Annual Cr 119
Tax Annual Cr 8658
Net Profit Annual Cr 258179
IndicatorMar 2024Mar 2023
Cash from Operating Activity Annual Cr 266191
Cash from Investing Activity Annual Cr -241-179
Cash from Financing Annual Activity Cr -20-13
Net Cash Flow Annual Cr 5-1
IndicatorMar 2024Mar 2023
Total ShareHolders Funds Annual Cr 1,4701,242
Fixed Assets Annual Cr 915685
Total Non Current Assets Annual Cr 1,017770
Total Current Assets Annual Cr 842807
Total Assets Annual Cr 1,8591,577
IndicatorMar 2024Mar 2023
Book Value Per Share Annual Rs 153129
ROE Annual % 1814
ROCE Annual % 2319
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 3027

Poly Medicure Technicals

EMA & SMA

Current Price
₹2,839.25
+ 23.95 (0.85%)
pointer
  • Bullish Moving Average
  • ___
  • 14
  • Bearish Moving Average
  • ___
  • 2
  • 20 Day
  • ₹2,657.88
  • 50 Day
  • ₹2,477.31
  • 100 Day
  • ₹2,282.79
  • 200 Day
  • ₹2,023.32
  • 20 Day
  • ₹2,602.53
  • 50 Day
  • ₹2,486.82
  • 100 Day
  • ₹2,253.86
  • 200 Day
  • ₹1,927.66

Poly Medicure Resistance and Support

PIVOT
₹2,836.3
Resistance
First Resistance 2,862.55
Second Resistance 2,885.85
Third Resistance 2,912.10
RSI 61.52
MFI 67.40
MACD Single Line 104.66
MACD 134.92
Support
First Support 2,813.00
Second Support 2,786.75
Third Supoort 2,763.45

Poly Medicure Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 195,038 11,842,707 60.72
Week 460,213 12,315,289 26.76
1 Month 264,958 7,516,861 28.37
6 Month 177,280 8,954,403 50.51

Poly Medicure Result Highlights

Poly Medicure Synopsis

NSE-Medical-Systems/Equip

Poly Medicure Ltd. is a prominent medical device company, recognized for manufacturing and exporting high-quality healthcare products. With 8 state-of-the-art manufacturing facilities across India, Italy, China, and Egypt, the company specializes in infusion therapy, dialysis, urology, diagnostics, and central venous access catheters. Serving healthcare providers for over two decades, Poly Medicure emphasizes innovation, safety, and quality in its product line. It has been awarded the “Medical Devices Company of the Year 2018” by the Government of India and is the largest exporter of medical devices from India for six consecutive years, ensuring high standards of patient care globally.
Market Cap 28,526
Sales 1,452
Shares in Float 3.75
No of funds 217
Yield 0.1
Book Value 18.53
U/D Vol ratio 2.2
LTDebt / Equity 1
Alpha 0.24
Beta 0.72

Poly Medicure Shareholding Pattern

Owner NameSep-24Jun-24Mar-24
Promoters 62.56%66.03%53.15%
Mutual Funds 7.35%6.29%4.99%
Insurance Companies 3.06%2.31%2.01%
Foreign Portfolio Investors 11.88%9.91%12.37%
Individual Investors 10.13%11.37%11.34%
Others 5.02%4.09%16.14%

Poly Medicure Management

Name Designation
Mr. Devendra Raj Mehta Chairman
Mr. Himanshu Baid Managing Director
Mr. Rishi Baid Joint Managing Director
Mr. Jugal Kishore Baid Non Executive Director
Mrs. Mukulika Baid Non Executive Director
Mr. Alessandro Balboni Non Executive Director
Dr. Shailendra Raj Mehta Ind. Non-Executive Director
Dr. Ambrish Mithal Ind. Non-Executive Director
Dr. Sandeep Bhargava Ind. Non-Executive Director
Mr. Vimal Bhandari Ind. Non-Executive Director
Mr. Amit Khosla Ind. Non-Executive Director
Ms. Sonal Mattoo Ind. Non-Executive Director

Poly Medicure Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Poly Medicure Corporate Action

Date Purpose Remarks
2024-10-28 Quarterly Results & ESOP
2024-07-22 Quarterly Results
2024-06-29 Others Inter alia, to consider and finalize the terms and condition and approve the modes of fund raising. per share(40%)Interim Dividend
2024-05-17 Audited Results & Final Dividend
2024-03-08 Others Inter alia, to consider a) Business Plan for Financial Year 2024-25. b) To consider and evaluate a proposal for raising of funds, in one or more tranches, through permissible mode(s). per share(40%)Interim Dividend

Poly Medicure FAQs

What is Share Price of Poly Medicure ?

Poly Medicure share price is ₹2,839 As on 07 November, 2024 | 02:23

What is the Market Cap of Poly Medicure ?

The Market Cap of Poly Medicure is ₹28768.9 Cr As on 07 November, 2024 | 02:23

What is the P/E ratio of Poly Medicure ?

The P/E ratio of Poly Medicure is 97.6 As on 07 November, 2024 | 02:23

What is the PB ratio of Poly Medicure ?

The PB ratio of Poly Medicure is 19.6 As on 07 November, 2024 | 02:23

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23